IMMUNOBIOLOGY PARP-1 regulates expression of TGF-b receptors in T cells
Pin Zhang,Hiroko Nakatsukasa,Eric Tu,Shimpei Kasagi,Kairong Cui,Masaki Ishikawa,Joanne E. Konkel,Takashi Maruyama,Gang Wei,Brittany Abbatiello,Zhao-Qi Wang,Keji Zhao,WanJun Chen
2013-01-01
Abstract:Transforming growth factor-b (TGF-b) receptor I (TbRI) and II (TbRII) are essential components of TGF-b signalingand play an indispensable role in generation of regulatory T cells (Tregs). In mice, selective deletion of TbRIor TbRII in T cells results in a severe defect in Treg generation. However, the underlying mechanisms are poorly understood. The expression of TbRs in T cells determines TGF-b signal strength, which has profound effects on T-cell responses and differentiation. Thus, insights into the mechanisms that regulate TbR expression are not only essential for understanding Treg generation, but also important for treatment of autoimmune diseases, transplant rejection, cancer, and infection. Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme that is conventionally linked to DNA repair. However, PARP-1 has also been shown to function as a transcription factor involved in the transcription of many genes. Inhibition of PARP-1 activity by inhibitors or gene mutation has been shown to lead to both suppression and exacerbation of chronic inflammation and autoimmune disease models. Recently, it was shown that deletion of PARP-1 inhibited nuclear factor–kB (NF-kB) activation and decreased tumor necrosis factor-a (TNF-a) and inducible nitric oxide synthesis in macrophages. However, the role of PARP-1 in T-cell–mediated immune responses remains elusive. Here, we show that PARP-1 regulates the expression of TbRs and thereby controls Treg generation in T cells. Deletion of PARP-1 in mice (PARP-1) results in a T-cell–intrinsic preference to generate more thymic Tregs and convert more naive T cells into induced Tregs in vitro and in vivo. Treg increase was attributed to enhanced sensitivity of CD4 T cells to TGF-b signals by upregulation of both TbRI and II, and subsequent Smad2/3 activation in PARP-1 T cells. We show that PARP-1 inhibits TbRI expression through its enzymatic function, and modulates TbRII by directly binding to TbRII gene (Tgfbr2). In addition, PARP-1 deficiency enriched the binding of Smad3 at the enhancer of the forkhead box p3 (Foxp3) gene. Importantly, inhibition of PARP-1 enzyme activity resulted in increased FOXP3 and TGFBR genes expression in human CD4 T cells. Together, these data reveal an unrecognized role for PARP1 in the regulation of TbR expression.